FdaApplication

ANDA 208283

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBRECKENRIDGE PHARMACEUTICAL INC
application_typeANDA
approval_date2018-09-14

Products (2)

ProductActive ingredientStrengthDosage form
EPLERENONEEPLERENONE50MGTABLET;ORAL
EPLERENONEEPLERENONE25MGTABLET;ORAL

2 products